Global /China /Healthcare /Drug Manufacturers - General /300583

Shandong Sito Bio-technology Co., Ltd.

300583

• SHE: 300583 • Delayed

15.12CNY 2%

2.23 USD

As of 14 June 2026, Shandong Sito Bio-technology Co., Ltd. has a market cap of $415.18M USD, ranking #16414 globally and #5142 in China. It ranks #1482 in the Healthcare sector, and #538 in the Drug Manufacturers - General industry.

Global Rank

16414

Country Rank

5142

Sector Rank

1482

Industry Rank

538

Key Stats

Market Cap

$415.18MUSD

2.81B CNY

Enterprise Value

$500.64MUSD

3.39B CNY

Revenue (TTM)

$140.9MUSD

954.76M CNY

EBITDA (TTM)

-$65.97KUSD

-446.47K CNY

Net Income (TTM)

-$25.49MUSD

-172.71M CNY

EBITDA Margin

Profit Margin

-18%

PS Ratio

2.9

PB Ratio

1.6

Company Profile

Country (HQ)

China

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Lianbiao Jin open_in_new

Employees

959

Founded

2002

Website

sitobiotech.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
2%	7.9%	4.5%	2.1%	-2.2%	8.3%	-22%	-2.4%	-0.5%

News

Markets

Exchange	Ticker	Price	Quotes
Shenzhen Stock Exchange (SHE / SZSE) MIC: XSHE PRIMARY	300583 山东赛托生物科技股份有限公司 Class A ISIN: CNE100002F36 Shares Out.: Shares Outstanding: 186.149M¹ Shares Float: 170.219M² TV: TradingView: SZSE: 300583 SA: Stock Analysis: SHE: 300583 YF: Yahoo Finance: 300583.SZ GF: Google Finance: SHE: 300583 BA: Barron's: 300583 MS: Morningstar: XSHE: 300583	15.12 CNY	TV: TradingView: SZSE: 300583 SA: Stock Analysis: SHE: 300583 YF: Yahoo Finance: 300583.SZ GF: Google Finance: SHE: 300583 BA: Barron's: 300583 MS: Morningstar: XSHE: 300583

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Shandong Sito Bio-technology Co., Ltd.

Shandong Sito Bio-technology Co., Ltd. researches, develops, and produces steroid biomedicine intermediates. Its products include 9α-hydroxyandrost, 17α-hydroxyprogesterone, 17α-hydroxy progesterone derivatives, anecort acetate, neomycin sulfate, progesterone intermediate, tylvalosin tartrate, tetraene acetate, androstenedione, bisnoralcohol, norandrostenedione, ethylene deltenone, 16β and 16α methyl epoxide, and hexahydro-3a-methyl, as well as androsta-1,4-diene-3,17-dione and estra-4,9-diene-3,17-dione. Shandong Sito Bio-technology Co., Ltd. was founded in 2002 and is based in Heze, China.

Similar Companies

Industry: Drug Manufacturers - General (China)

Name	Market Cap (USD) diff.	PE	Country
Jiangsu Hengrui Pharmaceuticals Co.,Ltd SSE: 600276	$53.85B 364.89B CNY 13K%	44.9	China
WuXi AppTec Co., Ltd. SSE: 603259	$49.64B 336.36B CNY 12K%	17.2	China
Hansoh Pharmaceutical Group Company Ltd. SHEK: 3692	$28.52B 223.48B HKD 7K%	35.7	China
Innovent Biologics, Inc. SHEK: 1801	$18.8B 147.32B HKD 4K%	162.3	China
Sichuan Biokin Pharmaceutical Co.,Ltd. SSE: 688506	$16.51B 111.89B CNY 4K%	-	China
Akeso, Inc. SHEK: 9926	$16.01B 125.46B HKD 4K%	-	China

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 183K%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 132K%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 87K%	97.4	United States
Roche Holding AG SIX: RO	$321.52B 256.25B CHF 77K%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$288.84B 215.59B GBP 69K%	27.6	United Kingdom
Novartis AG SIX: NOVN	$274.65B 218.9B CHF 66K%	20.5	Switzerland

chevron_leftBack